{"id":971897,"date":"2026-06-15T06:37:36","date_gmt":"2026-06-15T10:37:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/"},"modified":"2026-06-15T06:37:36","modified_gmt":"2026-06-15T10:37:36","slug":"sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/","title":{"rendered":"SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition \u2013 Current Shareholders Urged to Contact BFA Law"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW YORK, June  15, 2026  (GLOBE NEWSWIRE) &#8212; Leading securities law firm\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ko9_G3sRbZ3snJUEhkZDICEf4PxIryEGvZtPb4otjc9-IaoIZjGP8OJmjbzNcHkNxjuEeml1RWrt4tj88sJBZXgxdZIu090qk9Q0fM5eqDTRnOrM88eElDpgYC2yagcJLJ7E9oCaIoZhLa0LtGYdJoso8wppVJEyoe--rUcTQJc=\" rel=\"nofollow\" target=\"_blank\"><strong>Bleichmar Fonti &amp; Auld LLP<\/strong><\/a> announces an investigation into Select Medical Holdings Corporation\u2019s (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026.<\/p>\n<p align=\"left\">If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kc5G5he4LSeekgiBjA4E_-Bqt601ed2ItmwhaWYeoOkfZY1UYm7htfhY-yawt35PIXfcN21X3Xa72MprxhZQ1QiMLPasdVscSkPN5zSx-cnaG7hiInWxpzNY84MSO33I5BCCejPn0p3MKohUrG0waakTC8X-dzwD5haOCdiJKkwbA6pdEDjxM3muyCqS3uaq\" rel=\"nofollow\" target=\"_blank\"><strong>https:\/\/www.bfalaw.com\/cases\/select-medical-merger-lawsuit<\/strong><\/a><\/p>\n<p align=\"left\">\n        <strong>Why is Select Medical being Investigated? <\/strong>\n      <\/p>\n<p align=\"left\">On March 2, 2026, Select Medical announced that it had agreed to be acquired by a consortium led by: Robert A. Ortenzio, Select Medical\u2019s co-founder; Martin F. Jackson, Select Medical\u2019s Senior Executive Vice President of Strategic Finance and Operations; and Welsh, Carson, Anderson &amp; Stowe (\u201cWCAS\u201d), a private equity company which has longstanding historical ties to Russel L. Carson, a director on Select Medical\u2019s board of directors.<\/p>\n<p align=\"left\">The merger will eliminate all holdings of Select Medical stock in exchange for $16.50 per share in cash, except that Ortenzio, Jackson and certain entities affiliated with them are being allowed to \u201crollover\u201d their holdings into the post-merger company. The opportunity to \u201crollover\u201d is not being extended to public stockholders.<\/p>\n<p align=\"left\">The merger was approved by a special committee of Select Medical\u2019s board of directors and is conditioned on approval by Select Medical\u2019s stockholders.<\/p>\n<p align=\"left\">\n        <strong>The stockholder vote is scheduled for June 26, 2026. The merger could close shortly after that vote occurs, which could limit stockholders\u2019 ability to investigate the fairness of the merger.<\/strong>\n      <\/p>\n<p align=\"left\">BFA is investigating whether Select Medical\u2019s board of directors, together with members of the company\u2019s senior management, have breached their fiduciary duties to Select Medical stockholders in connection with the negotiation and execution of the merger, including the public disclosures the company has made seeking stockholder approval.<\/p>\n<p align=\"left\">\n        <strong>Click here for more information: <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kc5G5he4LSeekgiBjA4E_-Bqt601ed2ItmwhaWYeoOkfZY1UYm7htfhY-yawt35PIXfcN21X3Xa72MprxhZQ1V5pmgcOtKmz21jg5Kmh7GEzwo-twgf4RxLeXuhbLzejNU03DVIMGz6UVVM_bJdDyzgO20HDL8DpvKUFppZu8Q3zErFcHg5dm8J_03wh9ITV\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>https:\/\/www.bfalaw.com\/cases\/select-medical-merger-lawsuit<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p align=\"left\">\n        <strong>What Can You Do?<\/strong>\n      <\/p>\n<p align=\"left\">If you are a current holder of Select Medical Holdings Corporation stock, you may have legal options and are encouraged to submit your information to the firm.<\/p>\n<p align=\"left\">All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.<\/p>\n<p align=\"left\">\n        <strong>Submit your information by visiting:<\/strong>\n      <\/p>\n<p align=\"left\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kc5G5he4LSeekgiBjA4E_-Bqt601ed2ItmwhaWYeoOkfZY1UYm7htfhY-yawt35PIXfcN21X3Xa72MprxhZQ1Sw00dnAZm1gP44pyWYH7dUcbF34-9ho70cqFg87u9VUiSw5Aw5ipkvYZPNvJI9gRK17K-66M0EvdLpMJUYG6UpnAYF1RdTcFBKy51ALtlqO\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>https:\/\/www.bfalaw.com\/cases\/select-medical-merger-lawsuit<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p align=\"left\">Or contact:<\/p>\n<p align=\"left\">Adam McCall<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JK_JZc60PBkBPYL4b_uhx-Lr8yglAsxUD99tE7Tvk981SoeT-NUCtOO-nzNu7TkvJFD3QOqZpe6grYeq7BtJ2VSERQN8CPUvYJtGSkBL_VM=\" rel=\"nofollow\" target=\"_blank\">adam@bfalaw.com<\/a><br \/>212.789.3619<\/p>\n<p align=\"left\">\n        <strong>Why Bleichmar Fonti &amp; Auld LLP?<\/strong>\n      <\/p>\n<p align=\"left\">BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by <em>Chambers USA<\/em>, <em>The Legal 500<\/em>, and <em>ISS SCAS<\/em>, and its attorneys have been named \u201cElite Trial Lawyers\u201d by the <em>National Law Journal<\/em>, \u201cLitigation Stars\u201d by <em>Benchmark Litigation<\/em>, among the top \u201c500 Leading Plaintiff Financial Lawyers\u201d by <em>Lawdragon<\/em>, \u201cTitans of the Plaintiffs\u2019 Bar\u201d by <em>Law360<\/em> and \u201cSuperLawyers\u201d by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.\u2019s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.<\/p>\n<p align=\"left\">For more information about BFA and its attorneys, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kc5G5he4LSeekgiBjA4E_-Bqt601ed2ItmwhaWYeoOm3f2lDUfW2l_6eR13KpVg32uFvSjufq4bGM79J5_Wbysc8qC4TrqCddp8tJknHahA=\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.bfalaw.com<\/a>.<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kc5G5he4LSeekgiBjA4E_-Bqt601ed2ItmwhaWYeoOkfZY1UYm7htfhY-yawt35PIXfcN21X3Xa72MprxhZQ1YLfuxSdg4CQ9yMNgG4ljnNcS_4rYERx_5Ywaa5tlyu2JkY8pk5F3mQMW9UW56l1XwTn73V3M55PEFGiGxMjnjZLtt8hDqHY5h3oFFRx_kfz\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>https:\/\/www.bfalaw.com\/cases\/select-medical-merger-lawsuit<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p align=\"left\">\n        <em>Attorney advertising. Past results do not guarantee future outcomes.<\/em>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0NjMwOSM3NjU5NTkyIzIyOTA5OTU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YmIzNmZkNzMtODBiZi00NjdmLThhOGUtZjFjN2RiMDQ4Y2E4LTEzMDI1NDUtMjAyNi0wNi0xNS1lbg==\/tiny\/Bleichmar-Fonti-Auld.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) &#8212; Leading securities law firm\u00a0Bleichmar Fonti &amp; Auld LLP announces an investigation into Select Medical Holdings Corporation\u2019s (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https:\/\/www.bfalaw.com\/cases\/select-medical-merger-lawsuit Why is Select Medical being Investigated? On March 2, 2026, Select Medical announced that it had agreed to be acquired by a consortium led by: Robert A. Ortenzio, Select Medical\u2019s co-founder; Martin F. Jackson, Select Medical\u2019s Senior Executive Vice President of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition \u2013 Current Shareholders Urged to Contact BFA Law&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-971897","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition \u2013 Current Shareholders Urged to Contact BFA Law - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition \u2013 Current Shareholders Urged to Contact BFA Law - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) &#8212; Leading securities law firm\u00a0Bleichmar Fonti &amp; Auld LLP announces an investigation into Select Medical Holdings Corporation\u2019s (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https:\/\/www.bfalaw.com\/cases\/select-medical-merger-lawsuit Why is Select Medical being Investigated? On March 2, 2026, Select Medical announced that it had agreed to be acquired by a consortium led by: Robert A. Ortenzio, Select Medical\u2019s co-founder; Martin F. Jackson, Select Medical\u2019s Senior Executive Vice President of &hellip; Continue reading &quot;SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition \u2013 Current Shareholders Urged to Contact BFA Law&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-15T10:37:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0NjMwOSM3NjU5NTkyIzIyOTA5OTU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition \u2013 Current Shareholders Urged to Contact BFA Law\",\"datePublished\":\"2026-06-15T10:37:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\\\/\"},\"wordCount\":561,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0NjMwOSM3NjU5NTkyIzIyOTA5OTU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\\\/\",\"name\":\"SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition \u2013 Current Shareholders Urged to Contact BFA Law - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0NjMwOSM3NjU5NTkyIzIyOTA5OTU=\",\"datePublished\":\"2026-06-15T10:37:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0NjMwOSM3NjU5NTkyIzIyOTA5OTU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc0NjMwOSM3NjU5NTkyIzIyOTA5OTU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition \u2013 Current Shareholders Urged to Contact BFA Law\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition \u2013 Current Shareholders Urged to Contact BFA Law - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/","og_locale":"en_US","og_type":"article","og_title":"SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition \u2013 Current Shareholders Urged to Contact BFA Law - Market Newsdesk","og_description":"NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) &#8212; Leading securities law firm\u00a0Bleichmar Fonti &amp; Auld LLP announces an investigation into Select Medical Holdings Corporation\u2019s (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current shareholder of Select Medical, you are encouraged to obtain additional information by visiting: https:\/\/www.bfalaw.com\/cases\/select-medical-merger-lawsuit Why is Select Medical being Investigated? On March 2, 2026, Select Medical announced that it had agreed to be acquired by a consortium led by: Robert A. Ortenzio, Select Medical\u2019s co-founder; Martin F. Jackson, Select Medical\u2019s Senior Executive Vice President of &hellip; Continue reading \"SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition \u2013 Current Shareholders Urged to Contact BFA Law\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-15T10:37:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0NjMwOSM3NjU5NTkyIzIyOTA5OTU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition \u2013 Current Shareholders Urged to Contact BFA Law","datePublished":"2026-06-15T10:37:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/"},"wordCount":561,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0NjMwOSM3NjU5NTkyIzIyOTA5OTU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/","name":"SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition \u2013 Current Shareholders Urged to Contact BFA Law - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0NjMwOSM3NjU5NTkyIzIyOTA5OTU=","datePublished":"2026-06-15T10:37:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0NjMwOSM3NjU5NTkyIzIyOTA5OTU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc0NjMwOSM3NjU5NTkyIzIyOTA5OTU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sem-shareholder-news-select-medical-investors-may-have-rights-in-investigation-over-16-50-per-share-acquisition-current-shareholders-urged-to-contact-bfa-law\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SEM Shareholder News: Select Medical Investors may have Rights in Investigation over $16.50 per share Acquisition \u2013 Current Shareholders Urged to Contact BFA Law"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/971897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=971897"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/971897\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=971897"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=971897"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=971897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}